IL6R C ALS carriers have increased levels of IL6 and soluble IL6R in serum and CSF and accelerated disease progression rates;177 nevertheless, deletion of Il6 in Tg‐SOD1G93A did not alter the lifespan.178. This evidence concerns the gene IL6 and amyotrophic lateral sclerosis.